MIRA INFORM REPORT
|
Report Date : |
06.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
SWISS PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
164, Syh-Wei Street, Pu-Yuan
Sub-Ward., Yongkang Dist., Tainan City 710, |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
06.09.1966 |
|
|
|
|
Com. Reg. No.: |
68770700 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and trade of western medicine for human being |
|
|
|
|
No. of Employees
: |
190 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 3,600,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Contact
Points
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
158, Section 2, Minquan Road, North Dist,
Tainan City, Taiwan, R.O.C |
|
Supplied Address: |
158 Min chuan Rd Section 2 North Dist Tainan City 704, Taiwan |
|
Telephone Number: |
|
|
Fax Number: |
|
|
E-mail: |
Notes:
The exact address is above.
Credit
Summary
|
Credit Rating: |
|
|
Credit Opinion: |
Company
Identification Details
History
Subject was incorporated on
Shareholders
|
Subscription
Share |
|
|
Wenxiu Luo |
1,300,000 |
|
Changxia Luo |
|
|
1,300,000 |
|
|
Qinlong Liao |
1,300,000 |
|
Changmei Luo |
1,300,000 |
The information above is that of subject’s major shareholders.
Subsidiaries &
Branches
Factory:
|
Name |
164, Syh-Wei Street, Pu-Yuan Sub-Ward., Yongkang Dist., Tainan City
710, Taiwan (R.O.C.) |
Subject introduced
that it has a factory located the address as above, but the staff of subject
declined to disclose any more details about the factory.
Personnel
Information
Core
Management
|
1 |
|
|
Name |
Wenxiu Luo |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Changxia Luo |
|
Position |
Director |
|
3 |
|
|
Name |
Qinlong Liao |
|
Position |
Director |
|
4 |
|
|
Name |
Changmei Luo |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 190 Employees |
Operation
Information
Offices
& Factories
|
|
Headquarters |
|
Add |
158, Section 2, Minquan Road, North Dist, Tainan City, Taiwan, R.O.C |
Production
Information
l
Subject is a manufacturer of western medicine for human being with the
production activities
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
C802041 |
Manufacture of western medicines |
|
C802051 |
Manufacture of traditional Chinese medicines |
|
C802060 |
Manufacture of medicines for animals |
|
C802070 |
Manufacture of pesticide |
|
F108011 |
Wholesale of traditional Chinese medicines. |
|
F401010 |
International trade |
|
ZZ99999 |
Besides licensed business, all other business
items those are not banned or restricted. |
l
The components and raw material for production are
purchased from local and abroad.
· The subject is mainly engaged in manufacturing and trading of western medicine for human being and the related products.
· Subject introduced that the products of subject is the professional medicines for human beings, and it has about 200 sorts of western medicines.
· Subject’s selling territory covers all over the world.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Settlements
Subject declined
the settlements information, and from other sources, we couldn’t obtain the
information, either.
Financial
Information
Subject has no obligations to disclose its financial statements to the
third party according to the relevant policy in Taiwan and the only source from
which we can obtain the information is the subject itself.
Subject’s relevant staff Ms. Lin declined to disclose its financials
citing the grounds of company’s confidentiality; from other source we can not
obtain the relevant information, either.
Bankers
The bankers’ information is not available from the
subject or other sources.
Public
Record
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
Interview
Details
|
Name |
Ms. Lin |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.96 |
|
UK Pound |
1 |
Rs.77.47 |
|
Euro |
1 |
Rs.64.39 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.